top of page
ProPG_Shortages_72dpi.png

Dedicated to Excellence in Pharmaceutical Access

TGA, S19A, Special Access Scheme

Productos sin licencia 

ā€‹

Pro Pharmaceuticals Group tiene a mano en Melbourne una serie de medicamentos sin licencia de todo el mundo que suministramos a travƩs del Esquema de acceso especial, Prescriptor autorizado o vƭa S19a. Debido a las reglas de publicidad de TGA, no podemos enumerar los productos del Programa de acceso especial en nuestro sitio web; sin embargo, los hospitales pueden comunicarse con nosotros para solicitar productos.

 

Todos estos productos se almacenan en instalaciones con temperatura controlada y los distribuimos directamente a hospitales y farmacias minoristas a travĆ©s de nuestro proveedor de logĆ­stica externo. 

S19A Medicine Shortages

Pro Pharmaceuticals Group is a recognised leader in addressing medicine shortages across Australia, specialising in TGA S19A-approved products to fill urgent gaps in availability. Through our global network of trusted suppliers, we ensure timely and compliant access to critical and unlicensed medicines, supporting healthcare providers in delivering uninterrupted patient care.

 

Explore our extensive range of TGA S19A-listed medicines, tailored to meet the pressing needs of hospitals, pharmacies, and healthcare facilities. With a strong commitment to reliability and quality, Pro Pharmaceuticals Group is dedicated to bridging gaps in medicine supply and helping healthcare professionals navigate shortages with confidence.

ProPG S19A & TGA Product List 2025 Thumbnail.png
bottom of page